carbachol has been researched along with aclidinium bromide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beleta, J; Carcasona, C; Carreño, C; Cortijo, J; Doménech, T; Gavaldà, A; Gras, J; Llenas, J; Miralpeix, M; Morcillo, E; Otal, R; Ramos, I; Reyes, B; Ryder, H; Vilella, D; Viñals, M | 1 |
| Cortijo, J; Donet, E; Gavaldà, A; Mata, M; Milara, J; Miralpeix, M; Morcillo, EJ | 1 |
| Cortijo, J; Gavaldà, A; Milara, J; Miralpeix, M; Morcillo, EJ; Peiró, T; Serrano, A | 1 |
| Costa, L; Dekan, G; Lambers, C; Lardinois, D; Roth, M; Schuller, E; Ying, Q; Zhong, J | 1 |
4 other study(ies) available for carbachol and aclidinium bromide
| Article | Year |
|---|---|
Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
Topics: Administration, Inhalation; Anesthesia; Animals; Bronchi; Bronchoconstriction; Carbachol; CHO Cells; Cricetinae; Cricetulus; Dogs; Guinea Pigs; Heart Rate; Humans; Ipratropium; Male; Muscarinic Agonists; Muscarinic Antagonists; Receptors, Muscarinic; Scopolamine Derivatives; Stimulation, Chemical; Tiotropium Bromide; Trachea; Tropanes | 2009 |
Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways.
Topics: Carbachol; Cells, Cultured; Epithelial Cells; ErbB Receptors; Humans; Mitogen-Activated Protein Kinases; Mucin 5AC; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Respiratory System; RNA, Small Interfering; Smoking; Tropanes | 2011 |
Aclidinium inhibits human lung fibroblast to myofibroblast transition.
Topics: Actins; Bronchi; Carbachol; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Cholinergic Agonists; Collagen Type I; Dose-Response Relationship, Drug; Fibroblasts; Humans; Muscarinic Antagonists; Myofibroblasts; RNA, Messenger; Transforming Growth Factor beta1; Tropanes; Up-Regulation | 2012 |
Aclidinium bromide combined with formoterol inhibits remodeling parameters in lung epithelial cells through cAMP.
Topics: Bronchodilator Agents; Carbachol; Cells, Cultured; Cyclic AMP; Drug Therapy, Combination; Epithelial Cells; Extracellular Matrix; Formoterol Fumarate; Humans; Lung; Muscarinic Antagonists; p38 Mitogen-Activated Protein Kinases; Pulmonary Disease, Chronic Obstructive; Smad Proteins; Transforming Growth Factor beta1; Tropanes | 2015 |